Inventor

William L. Neumann

Inventor

St. Louis, MO, US

Overview

1992–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 53 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds27%

A61KPreparations for medical, dental or toiletry purposes26%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%

C07CAcyclic or carbocyclic compounds5%

A61LMethods or apparatus for sterilising materials or objects in general3%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%

B01JChemical or physical processes, e.g. catalysis or colloid chemistry2%

C07BGeneral methods of organic chemistry2%

A61MDevices for introducing media into, or onto, the body2%

C07KPeptides2%

PatentTitleYear

10,967,096Tissue sealant compositions, vascular closure devices, and uses thereof2021 10,960,104Tissue sealant compositions, vascular closure devices, and uses thereof2021 10,881,759Tissue sealant compositions, vascular closure devices, and uses thereof2021 10,617,687Fluorescent pyrazine derivatives and methods of using the same in assessing renal function2020 10,370,362Pyrazine derivatives with extended conjugation and methods of using the same in optical applications2019 RE047413Pyrazine derivatives and uses thereof in renal monitoring2019 RE047255Pyrazine derivatives and uses thereof in renal monitoring2019 9,662,387'Functional, cross-linked nanostructures for tandem optical imaging and therapy'2017 9,480,687'Pyrazine derivatives and uses thereof in renal monitoring'2016 9,433,700'Tissue sealant compositions, vascular closure devices, and uses thereof'2016 9,376,399'Fluorescent pyrazine derivatives and methods of using the same in assessing renal function'2016 9,295,650'Functional, cross-linked nanostructures for tandem optical imaging and therapy'2016 9,216,963'Pyrazine derivatives with extended conjugation and methods of using the same in optical applications'2015 9,150,837'Polyethylene glycolated superoxide dismutase mimetics'2015 9,114,160'Pyrazine derivatives and uses thereof in renal monitoring'2015 9,005,581'Modified pyrazine derivatives and uses thereof'2015 8,778,309'Fluorescent pyrazine derivatives and methods of using the same in assessing renal function'2014 8,722,685'Pyrazine derivatives and uses thereof in renal monitoring'2014 8,703,100'Modified pyrazine derivatives and uses thereof'2014 8,697,871'Integrated photoactive agents and uses thereof'2014 8,697,033'Modified pyrazine derivatives and uses thereof'2014 8,628,751'Pyrazine derivatives for optical imaging and therapy'2014 8,481,734'Pyrazine derivatives and uses thereof, including in medical imaging and visualization applications'2013 8,350,032'Integrated photoactive agents for real-time monitoring of hemostasis'2013 8,313,729'Integrated photoactive small molecules and uses thereof'2012 8,217,166'Polyethylene glycolated superoxide dismutase mimetics'2012 8,115,000'Pyrazine derivatives and uses thereof in renal monitoring'2012 7,407,645'Bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands'2008 7,119,094'Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade'2006 7,105,559'Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade'2006 7,015,223'Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade'2006 6,969,715'6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade'2005 6,916,847'Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade'2005 6,908,919'Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade'2005 6,906,068'Substituted polycyclic aryl and heteroaryl 1,2,4 - triazinones useful as anticoagulants'2005 6,875,791'Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade'2005 6,828,338'Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade'2004 6,750,342'Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade'2004 6,693,121'Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade'2004 6,664,255'Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade'2003 6,653,316'Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade'2003 6,624,180'Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade'2003 6,525,041'Manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide'2003 6,214,817'Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity'2001 6,204,259'Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide'2001 5,976,498'Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands'1999 5,908,931'Preorganized hexadentate ligands useful in radiographic imaging agents'1999 5,648,060'Preorganized hexadentate ligands useful in radiographic imaging agents'1997 5,248,498'Fullerene compositions for magnetic resonance spectroscopy and imaging'1993 5,243,073'Hexadentate ligands useful in radiographic imaging agents'1993 5,112,595'99MTC(III) myocardial imaging agents and method of use'1992 5,112,594'Kit for preparing a technetium-99m myocardial imaging agent'1992 5,105,014'Synthesis of vicinal diamines'1992

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1992–1999Based in Grover, MO, US· patent location history

1999–2008Based in Ballwin, MO, US· patent location history

2001–2017Based in Kirkwood, MO, US· patent location history

2003–2006Patents assigned to PHARMACIA CORP (14)· patent assignee history

2003–2021Based in St. Louis, MO, US· patent location history

2012–2016Patents assigned to NEUMANN WILLIAM L (13)· patent assignee history

2012–2016Patents assigned to MEDIBEACON LLC (10)· patent assignee history

2012–2016Patents assigned to DORSHOW RICHARD B (9)· patent assignee history

2015–2021Patents assigned to MEDIBEACON INC (10)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
PHARMACIA CORP	14	2003–2006
NEUMANN WILLIAM Lself	13	2012–2016
MEDIBEACON INC	10	2015–2021
MEDIBEACON LLC	10	2012–2016
DORSHOW RICHARD B	9	2012–2016

Locations

Location	Patents	Span
St. Louis, MO, US	39	2003–2021
Grover, MO, US	7	1992–1999
Kirkwood, MO, US	4	2001–2017
Ballwin, MO, US	3	1999–2008